Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy

Journal of Gastroenterology

Volumn 47, Issue 5, 2012, Pages 491-497

  Terai, Shuji ^a   Tanimoto, Haruko ^a   Maeda, Masaki ^a   Zaitsu, Junichi ^a   Hisanaga, Takuro ^a   Iwamoto, Takuya ^a   Fujisawa, Koichi ^a   Mizunaga, Yuko ^a   Matsumoto, Toshihiko ^a   Urata, Yohei ^a   Marumoto, Yoshio ^a   Hidaka, Isao ^a   Ishikawa, Tsuyoshi ^a   Yokoyama, Yuichiro ^a   Aoyama, Koji ^a   Tsuchiya, Masako ^a   Takami, Taro ^a   Omori, Kaoru ^a   Yamamoto, Naoki ^a   Segawa, Makoto ^a   Uchida, Koichi ^a   Yamasaki, Takahiro ^a   Okita, Kiwamu ^b   Sakaida, Isao ^a   more..

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Social Insurance Allied Shimonoseki Kosei Hospital   (Japan)

Author keywords

ABMi therapy; Cell therapy; Liver cirrhosis; Liver regeneration

Indexed keywords

BIOLOGICAL MARKER; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA;

AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW CELL; CANCER RISK; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; DISEASE ASSOCIATION; FEASIBILITY STUDY; HEPATITIS B VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LONG TERM CARE; MESENCHYMAL STEM CELL; MONONUCLEAR CELL; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SPLENECTOMY; STEM CELL TRANSPLANTATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CARCINOMA, HEPATOCELLULAR; DISEASE MODELS, ANIMAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER REGENERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; SPLENECTOMY;

EID: 84865136596     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-012-0580-5     Document Type: Review

References (32)

1. Theise ND, Badve S, Saxena R, Henegariu O, Sell S, Crawford JM, Krause DS. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology. 2000;31:235-40. (Pubitemid 30033713)
2. Terai S, Sakaida I, Yamamoto N, Omori K, Watanabe T, Ohata S, Katada T, et al. An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes. J Biochem (Tokyo). 2003;134:551-8. (Pubitemid 37442878)
3. Terai S, Sakaida I, Nishina H, Okita K. Lesson from the GFP/CCl4 model-translational research project: the development of cell therapy using autologous bone marrow cells in patients with liver cirrhosis. J Hepatobiliary Pancreat Surg. 2005;12:203-7. (Pubitemid 40975520)
4. Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, Meyer EM, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 2002;416:542-5. (Pubitemid 34288856)
5. Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, Nishina H, Okita K. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology. 2004;40:1304-11. (Pubitemid 39657004)
6. Iimuro Y, Nishio T, Morimoto T, Nitta T, Stefanovic B, Choi SK, Brenner DA, et al. Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology. 2003;124:445-58. (Pubitemid 36169261)
7. Higashiyama R, Inagaki Y, Hong YY, Kushida M, Nakao S, Niioka M, Watanabe T, et al. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice. Hepatology. 2007;45:213-22. (Pubitemid 46144381)
8. Siller-Lopez F, Sandoval A, Salgado S, Salazar A, Bueno M, Garcia J, Vera J, et al. Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis. Gas-troenterology. 2004;126:1122-33. (discussion 1949). (Pubitemid 38451183)
9. Ishikawa T, Terai S, Urata Y, Marumoto Y, Aoyama K, Murata T, Mizunaga Y, et al. Administration of fibroblast growth factor 2 in combination with bone marrow transplantation synergistically improves carbon-tetrachloride-induced liver fibrosis in mice. Cell Tissue Res. 2007;327:463-70. (Pubitemid 46232316)
10. Ishikawa T, Terai S, Urata Y, Marumoto Y, Aoyama K, Sakaida I, Murata T, et al. Fibroblast growth factor 2 facilitates the differentiation of transplanted bone marrow cells into hepatocytes. Cell Tissue Res. 2006;323:221-31. (Pubitemid 43100264)
11. Hisanaga T, Terai S, Iwamoto T, Takami T, Yamamoto N, Mu-rata T, Matsuyama T, et al. TNFR1-mediated signaling is important to induce the improvement of liver fibrosis by bone marrow cell infusion. Cell Tissue Res. 2011;346:79-88.
12. Nishina H, Vaz C, Billia P, Nghiem M, Sasaki T, De la Pompa JL, Furlonger K, et al. Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4. Development. 1999;126:505-16. (Pubitemid 29082037)
13. Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, Yokoyama Y, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells. 2006;24:2292-8. (Pubitemid 44527483)
14. Kim JK, Park YN, Kim JS, Park MS, Paik YH, Seok JY, Chung YE, et al. Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis. Cell Transpl. 2010;19:1237-46.
15. Saito T, Okumoto K, Haga H, et al. Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis. Stem Cells Dev. 2011;20(9):1503-10.
16. Lyra AC, Soares MB, da Silva LF, Fortes MF, Silva AG, Mota AC, Oliveira SA, et al. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol. 2007;13:1067-73. (Pubitemid 46511008)
17. Lyra AC, Soares MB, dos Santos RR, Lyra LG. Bone marrow stem cells and liver disease. Gut. 2007;56:1640. (author reply 1640-1641).
18. Am Esch JS 2nd, Knoefel WT, Klein M, Ghodsizad A, Fuerst G, Poll LW, Piechaczek C, et al. Portal application of autologous CD133? bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells. 2005;23:463-70. (Pubitemid 40478484)
19. Mohamadnejad M, Namiri M, Bagheri M, Hashemi SM, Gha-naati H, Zare Mehrjardi N, Kazemi Ashtiani S, et al. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol. 2007;13:3359-63. (Pubitemid 47062247)
20. Gordon MY, Levicar N, Pai M, Bachellier P, Dimarakis I, Al-Allaf F, M'Hamdi H, et al. Characterization and clinical application of human CD34? stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells. 2006;24:1822-30. (Pubitemid 44474196)
21. Spahr L, Lambert JF, Rubbia-Brandt L, Chalandon Y, Frossard JL, Giostra E, Hadengue A. Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial. Hepatology. 2008;48:221-9. (Pubitemid 351975547)
22. Pai M, Zacharoulis D, Milicevic MN, Helmy S, Jiao LR, Levicar N, Tait P, et al. Autologous infusion of expanded mobilized adult bone marrow-derived CD34? cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol. 2008;103:1952-8.
23. Han Y, Yan L, Han G, Zhou X, Hong L, Yin Z, Zhang X, et al. Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulo-cyte-colony-stimulating factor mobilization therapy. Cytothera-py. 2008;10:390-6. (Pubitemid 351983162)
24. Falzetti F, Aversa F, Minelli O, Tabilio A. Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor. Lancet. 1999;353:555. (Pubitemid 29078428)
25. Iwamoto T, Terai S, Mizunaga Y, Yamamoto N, Omori K, Uchida K, Yamasaki T, et al. Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients. J Gastroenterol. 2011 Epub ahead of print.
26. Mizunaga Y, Terai S, Yamamoto N, Uchida K, Yamasaki T, Nishina H, Fujita Y, Shinoda K, Hamamoto Y, Sakaida I. Granulocyte colony-stimulating factor and interleukin-1b are important cytokine in repair of the cirrhotic liver after bone marrow cell infusion-comparison of humans and model mice. Cell Transpl. 2013 (in press).
27. Peng L, Xie DY, Lin BL, et al. Autologous bone marrow mes-enchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology. 2011;54(3):820-828.
28. Maeda M, Takami T, Terai S, Sakaida I. Autologous bone marrow cell infusions suppress tumor initiation in hepatocarcinogenic mice with liver cirrhosis. J Gastroenterol Hepatol. 2012;27(Suppl 2):104-11.
29. Thomas JA, Pope C, Wojtacha D, Robson AJ, Gordon-Walker TT, Hartland S, Ramachandran P, et al. Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibro-sis, regeneration, and function. Hepatology. 2011;53:2003-15.
30. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M, Ghanaati H, Baharvand H, et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med. 2007;10:459-66. (Pubitemid 350001896)
31. Kharaziha P, Hellstrom PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, Telkabadi M, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol. 2009;21:1199-205.
32. Amer ME, El-Sayed SZ, El-Kheir WA, Gabr H, Gomaa AA, El-Noomani N, Hegazy M. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells. Eur J Gastroenterol Hep-atol. 2011;23:936-41.